Jennifer Thompson, Medtronic’s vice president of U.S. aortic sales, detailed how AI is transforming medical device commercialization during a fireside chat at Reuters’ MedTech conference. The technology is helping teams identify patients, optimize their sales deployment and discover care bottlenecks. The post Medtronic Exec: AI Is Improving Device Launches & Patient Outcomes appeared first on…
By safety and cautiously integrating LLMs in a clinician setting, we have the potential for the ultimate levels of personalization: the perfect words for the right person at the right time. The post Therapy 2.0: An AI-Powered Science of Language Intervention appeared first on MedCity News.
Salivary testing represents more than a new tool; it’s a scalable strategy to shift care upstream, reduce preventable emergencies, and bring equity to a population too often left behind. The post The Critical Role Payers Can Play in Closing the Oral Health Gap appeared first on MedCity News.
During Reuters’ MedTech conference, medical device leaders shared three common misconceptions they believe hospital leaders often have about AI. They stressed that AI in healthcare is meant to augment — not replace — clinicians. The post 3 Misconceptions Hospital Leaders Have About AI appeared first on MedCity News.
Health tech companies made several major funding announcements in October. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in October appeared first on MedCity News.
Suzy Lohman felt compelled to act when she learned that foster children treated at Cincinnati Children’s Hospital Medical Center often lacked proper bags for their belongings. Inspired by a hospital newsletter request for suitcases, duffel bags, and backpacks, Suzy launched a drive among EVS employees to collect these essential items. Many foster children, she knew, relied…
Pfizer claims Metsera breached their merger agreement, adding that a tie-up of the biotech with GLP-1 drug giant Novo Nordisk would violate U.S. antitrust law. Metsera called the arguments “nonsense” and said Pfizer is trying to buy the obesity drug developer for less than what Novo is willing to pay. The post Pfizer Lawsuits Allege…
Now that the “Big Beautiful Bill” has been enacted, U.S. health systems may face a seismic financial shakeup. The most resilient organizations are using this moment to rethink their infrastructure, and modernizing payments is one of the most logical places to start. The post The ROI Hospitals Can’t Afford to Ignore: Payment Modernization appeared first…
The future of primary care will be collaborative by design. Clinicians will continue to be the first call and the trusted guide, but they will be supported by scientific partners who shorten the distance between breakthrough and bedside. The post The Primary Care Clinician of the Future Won’t Practice Alone: The Power of Scientific Partnerships…
[Sponsored] In this webinar on November 19th, executives will share the need for accountability and proof in benefits design. Sign up today! The post Webinar on ROI Reality Check: Separating Hype from Health Impact appeared first on MedCity News.